INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $887,257 | -9.2% | 28,060 | +17.1% | 0.03% | -6.2% |
| Q2 2023 | $976,966 | +9.4% | 23,957 | 0.0% | 0.03% | +3.2% |
| Q1 2023 | $892,877 | +47.7% | 23,957 | +38.3% | 0.03% | +47.6% |
| Q4 2022 | $604,434 | -57.0% | 17,324 | -31.0% | 0.02% | -59.6% |
| Q3 2022 | $1,405,000 | -45.9% | 25,099 | -50.0% | 0.05% | +13.0% |
| Q2 2022 | $2,598,000 | +42.4% | 50,198 | +100.0% | 0.05% | -20.7% |
| Q1 2022 | $1,824,000 | -25.5% | 25,099 | +21.2% | 0.06% | -21.6% |
| Q4 2021 | $2,448,000 | +5.9% | 20,705 | +20.2% | 0.07% | -2.6% |
| Q3 2021 | $2,311,000 | -19.6% | 17,228 | -3.0% | 0.08% | -20.8% |
| Q2 2021 | $2,875,000 | +101.8% | 17,755 | 0.0% | 0.10% | +81.1% |
| Q1 2021 | $1,425,000 | – | 17,755 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |